StocksFundsScreenerSectorsWatchlists
STE

STE - STERIS PLC Stock Price, Fair Value and News

199.34USD-1.47 (-0.73%)Delayed as of 19 Apr 2024, 02:28 pm ET

Market Summary

STE
USD199.34-1.47
Delayedas of 19 Apr 2024, 02:28 pm
-0.73%

STE Stock Price

View Fullscreen

STE RSI Chart

STE Valuation

Market Cap

19.8B

Price/Earnings (Trailing)

34.98

Price/Sales (Trailing)

3.67

EV/EBITDA

16.4

Price/Free Cashflow

33.38

STE Price/Sales (Trailing)

STE Profitability

Operating Margin

45.49%

EBT Margin

12.62%

Return on Equity

8.84%

Return on Assets

4.96%

Free Cashflow Yield

3%

STE Fundamentals

STE Revenue

Revenue (TTM)

5.4B

Rev. Growth (Yr)

14.77%

Rev. Growth (Qtr)

3.97%

STE Earnings

Earnings (TTM)

566.8M

Earnings Growth (Yr)

13.66%

Earnings Growth (Qtr)

22.05%

Breaking Down STE Revenue

52 Week Range

180.54254.00
(Low)(High)

Last 7 days

-2.7%

Last 30 days

-12.8%

Last 90 days

-9.4%

Trailing 12 Months

7.5%

How does STE drawdown profile look like?

STE Financial Health

Current Ratio

2.43

Debt/Equity

0.5

Debt/Cashflow

0.29

STE Investor Care

Dividend Yield

0.99%

Dividend/Share (TTM)

1.98

Buy Backs (1Y)

0.47%

Diluted EPS (TTM)

5.71

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20235.0B5.1B5.2B5.4B
20224.6B4.8B4.8B4.8B
20213.1B3.4B3.8B4.2B
20203.0B3.0B3.0B3.1B
20192.8B2.8B2.9B3.0B
20182.0B2.0B2.7B2.7B
20172.6B2.5B2.3B2.2B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of STERIS PLC

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Dec 04, 2023
xilas andrew
sold (taxes)
-19,528
199
-98.00
svp and gm, dental
Dec 04, 2023
xilas andrew
acquired
-
-
333
svp and gm, dental
Oct 09, 2023
xilas andrew
sold (taxes)
-40,194
225
-178
svp and gm, dental
Oct 09, 2023
xilas andrew
acquired
-
-
605
svp and gm, dental
Oct 02, 2023
carestio daniel a
sold (taxes)
-28,015
215
-130
president and ceo
Oct 02, 2023
xilas andrew
sold (taxes)
-18,317
215
-85.00
svp and gm, dental
Oct 02, 2023
zangerle john adam
sold (taxes)
-13,145
215
-61.00
sr. vp, gen counsel, and sec.
Oct 02, 2023
burton karen l
sold (taxes)
-5,603
215
-26.00
vp, controller & cao
Oct 02, 2023
madsen julia
sold (taxes)
-36,850
215
-171
senior vp, life sciences
Jun 02, 2023
burton karen l
sold (taxes)
-26,094
205
-127
vp, controller & cao

1–10 of 50

Which funds bought or sold STE recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 17, 2024
Portside Wealth Group, LLC
reduced
-0.15
12,315
596,897
0.11%
Apr 17, 2024
Annapolis Financial Services, LLC
unchanged
-
89.00
4,047
-%
Apr 17, 2024
NEW MEXICO EDUCATIONAL RETIREMENT BOARD
added
13.59
282,000
1,414,000
0.05%
Apr 17, 2024
Stanley-Laman Group, Ltd.
added
9.79
427,750
3,914,790
0.55%
Apr 16, 2024
OneAscent Financial Services LLC
added
6.06
28,000
354,000
0.04%
Apr 16, 2024
Stratos Wealth Partners, LTD.
added
3.86
188,115
3,222,170
0.05%
Apr 16, 2024
Asset Dedication, LLC
unchanged
-
3,000
77,000
0.01%
Apr 16, 2024
Kohmann Bosshard Financial Services, LLC
unchanged
-
9,790
442,895
0.06%
Apr 16, 2024
WD RUTHERFORD LLC
unchanged
-
13,043
616,007
0.32%
Apr 16, 2024
Trifecta Capital Advisors, LLC
sold off
-100
-6,156
-
-%

1–10 of 50

Are Funds Buying or Selling STE?

Are funds buying STE calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own STE
No. of Funds

Unveiling STERIS PLC's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
12.01%
11,864,459
SC 13G/A
Feb 09, 2024
blackrock inc.
10.3%
10,135,140
SC 13G/A
Feb 09, 2024
massachusetts financial services co /ma/
5.9%
5,811,818
SC 13G/A
Jan 30, 2024
wcm investment management, llc
4.9%
4,850,134
SC 13G/A
Dec 06, 2023
blackrock inc.
10.2%
10,064,203
SC 13G/A
Feb 10, 2023
wcm investment management, llc
5.6%
5,563,771
SC 13G/A
Feb 09, 2023
vanguard group inc
11.99%
11,966,040
SC 13G/A
Feb 08, 2023
blackrock inc.
8.7%
8,710,879
SC 13G
Feb 08, 2023
massachusetts financial services co /ma/
5.0%
5,038,403
SC 13G
Feb 03, 2022
blackrock inc.
8.1%
8,128,575
SC 13G/A

Recent SEC filings of STERIS PLC

View All Filings
Date Filed Form Type Document
Apr 11, 2024
8-K
Current Report
Feb 23, 2024
3
Insider Trading
Feb 13, 2024
SC 13G/A
Major Ownership Report
Feb 09, 2024
SC 13G/A
Major Ownership Report
Feb 09, 2024
SC 13G/A
Major Ownership Report
Feb 08, 2024
10-Q
Quarterly Report
Feb 07, 2024
8-K
Current Report
Jan 30, 2024
SC 13G/A
Major Ownership Report

Peers (Alternatives to STERIS PLC)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
182.6B
40.1B
-6.98% -6.26%
31.91
4.55
-8.12% -17.45%
67.4B
19.5B
-2.95% -9.93%
53.63
3.46
4.02% -22.04%
22.6B
3.9B
-4.96% -15.40%
50.88
5.86
3.42% 23.09%
20.1B
14.8B
-5.44% -9.06%
7.58
1.36
2.12% 209.17%
MID-CAP
9.2B
3.5B
-0.25% 17.23%
32.28
2.63
4.97% 18.89%
9.0B
12.3B
-5.97% -15.68%
21.61
0.73
-2.44% -22.68%
8.2B
2.7B
-16.50% -42.23%
-12.88
3.07
-4.68% 82.43%
6.3B
4.0B
-8.09% -25.03%
-46.91
1.59
1.10% 85.84%
3.4B
366.4M
-2.40% 13.34%
-563.48
9.33
33.86% 89.83%
2.3B
6.6B
-5.10% -3.56%
11.79
0.35
2.78% -0.87%
SMALL-CAP
1.2B
3.2B
-10.67% -21.18%
-1.84
0.39
7.73% -1066.14%
377.6M
166.7M
0.43% -6.80%
-4.57
2.27
6.67% -456.34%
245.1M
324.0M
10.27% -31.54%
-1.27
0.76
-3.19% -337.41%
47.8M
52.3M
-23.89% -53.56%
-2.55
0.91
17.61% 19.28%
3.7M
3.7M
-12.80% 240.48%
-0.3
0.99
5.77% 8.23%

STERIS PLC News

Latest updates
Simply Wall St5 hours ago
MarketBeat17 Apr 202410:51 am
Seeking Alpha14 Apr 202409:56 am
Yahoo Finance28 Mar 202407:00 am

STERIS PLC Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue4.0%1,3961,3421,2851,3851,2161,2011,1561,2111,2091,197968874809756669823774737697768696
Cost Of Revenue5.9%793749711-694668639-671717542-463426382459443418391433409
Gross Profit1.5%603594573588521532518572538480426380346330287363331319307335287
Operating Expenses-5.2%386408385363331839359480335364412236199189172206189192196194217
  S&GA Expenses-5.3%361381359336305323335454311345394221182173155189173176179173176
  R&D Expenses-4.2%26.0027.0026.0026.0026.0025.0025.0026.0025.0019.0018.0018.0016.0016.0016.0017.0016.0016.0016.0016.0015.00
EBITDA Margin-1.1%0.26*0.26*0.17*0.17*0.16*0.16*0.25*0.21*0.20*0.19*0.20*0.25*---------
Interest Expenses5.4%39.0037.0032.0031.0029.0026.0023.0022.0023.0023.0022.0010.009.009.009.0010.0010.0010.0010.0011.0011.00
Income Taxes13.4%38.0034.0034.008.0037.00-17.8324.0019.0039.0020.00-7.0749.0025.0028.0019.0025.0029.0022.0015.0024.009.00
Earnings Before Taxes19.4%179150158195160-33313571.0018290.00-28.9813613913410914813411799.0013358.00
EBT Margin-0.6%0.13*0.13*0.04*0.03*0.01*0.01*0.10*0.07*0.09*0.09*0.11*0.17*---------
Net Income22.0%141115124187124-31511152.0014470.00-21.8187.0011510690.0012310595.0085.0010948.00
Net Income Margin-0.3%0.10*0.11*0.02*0.02*-0.01*0.00*0.08*0.05*0.07*0.06*0.08*0.13*---------
Free Cashflow174.4%17263.0021514411421.0011699.0016394.0041.00113---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q1
Assets1.4%11,43511,28110,78410,82210,80010,49011,18811,42411,69011,75212,1016,5746,5815,4935,3645,4415,3365,1865,2305,0735,200
  Current Assets2.1%2,2192,1742,0312,0111,9771,8881,8481,8791,9271,9052,0081,2121,1761,1501,0971,2241,0531,0321,0441,054990
    Cash Equivalents-8.5%196214209208259258316348359383535221253312256320199226238221202
  Inventory4.2%856821769695694645620575595565593315294279277264252237234208206
  Net PPE5.8%1,8441,7441,7261,7061,6711,5721,5731,5531,5221,5111,4991,2351,2271,1761,1481,1121,1031,0661,0541,0321,011
  Goodwill1931.5%4,1122023,8873,8793,8533,7054,3214,4045,1155,1335,2873,0262,9272,4182,3722,3562,4042,3192,3472,3232,434
Liabilities-1.7%5,0075,0914,6064,7354,7514,6764,7694,8795,0665,2085,5162,6832,7031,8301,8742,0231,9401,9481,9851,8871,983
  Current Liabilities4.6%9148738878627968739089229047861,145578506435480504451428433465398
  Short Term Borrowings10.6%78.0071.0063.0060.0060.0015115114312822.007.00---35.00------
  Long Term Debt-4.0%3,2313,3662,8603,0193,0022,8742,8462,9453,1753,4223,2571,6511,7131,0211,0221,1511,1371,1871,2101,1831,316
    LT Debt, Non Current-4.0%3,2313,3662,8603,0193,0022,8742,8462,9453,1753,4223,2571,6511,7131,0211,0221,1511,1371,1871,2101,1831,316
Shareholder's Equity3.7%6,4156,1896,1786,0776,0495,8136,4196,5456,6246,5456,5853,8913,8913,6753,50313.003,3963,2383,2458.0011.00
  Retained Earnings4.3%2,1342,0461,9811,9121,7711,6952,0571,9991,9901,8931,8751,9391,8731,7871,7001,6591,5441,4731,3971,3391,146
Shares Outstanding0.0%99.0099.0099.0099.0099.0010010010010010010085.00---------
Minority Interest14.5%13.0011.0010.0010.0010.0011.0012.0012.0012.009.0010.0010.0011.0015.0015.0013.0013.009.008.008.0011.00
Float------16,561---20,355---14,958---12,164---
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations99.4%291,243146,095281,129215,799205,578103,824231,746171,731244,314171,34097,426187,855205,712161,951134,122199,233131,326150,663109,337178,926133,877
  Share Based Compensation-26.2%15,29320,71611,5799,0949,34611,5488,9639,7519,99911,31026,6006,0426,0237,9395,9624,9495,5867,7395,5375,6085,419
Cashflow From Investing80.4%-118,921-606,237-66,596-77,578-98,410-97,925-109,41793,576-79,800-76,803-603,532-118,256-923,040-46,139-66,724-59,746-74,531-101,151-84,307-73,662-71,406
Cashflow From Financing-142.1%-197,994470,214-213,637-191,947-120,409-44,948-141,414-274,608-189,265-239,107818,810-96,913641,852-65,319-134,000-9,272-90,345-55,922-7,607-110,984-43,947
  Dividend Payments0.0%51,37851,36846,42746,60046,91746,97343,00843,05143,01142,95934,14834,14134,13634,08931,47131,43931,37531,39728,82328,75328,745
  Buy Backs355.6%2,2284898,724154,61384,03045,24324,67928,1492,87714,08110,67086.0012713814,29610,9202,45422,98114,88625,239354

STE Income Statement

2023-12-31
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Revenues:    
Revenues$ 1,395,645$ 1,215,994$ 4,022,547$ 3,573,002
Cost of revenues:    
Total cost of revenues793,052694,4972,252,9642,001,372
Gross Profit602,593521,4971,769,5831,571,630
Operating expenses:    
Selling, general, and administrative360,518305,1411,100,227962,962
Goodwill impairment loss000490,565
Research and development25,91325,51478,45975,193
Restructuring Costs6392127
Total operating expenses386,437330,6941,178,6881,528,847
Income from operations216,156190,803590,89542,783
Non-operating expenses, net:    
Interest expense38,94728,559108,24877,356
Interest income and miscellaneous expense(2,080)1,906(4,710)3,200
Total non-operating expenses, net36,86730,465103,53880,556
Income before income tax expense179,289160,338487,357(37,773)
Income tax expense38,34437,013106,27643,378
Net Income140,945123,325381,081(81,151)
Less: Net Income Attributable to Noncontrolling Interest202(503)1,465(956)
Net Income (Loss) Attributable to Shareholders$ 140,743$ 123,828$ 379,616$ (80,195)
Net income per common share [Abstract]    
Basic$ 1.42$ 1.24$ 3.84$ (0.80)
Diluted1.421.243.82(0.80)
Cash dividends declared per common share outstanding$ 0.52$ 0.47$ 1.51$ 1.37
Product [Member]    
Revenues:    
Revenues$ 804,756$ 679,042$ 2,280,950$ 1,982,512
Cost of revenues:    
Cost of Goods and Services Sold439,005374,7291,223,4151,058,663
Service [Member]    
Revenues:    
Revenues590,889536,9521,741,5971,590,490
Cost of revenues:    
Cost of Goods and Services Sold$ 354,047$ 319,768$ 1,029,549$ 942,709

STE Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)
$ in Thousands
Dec. 31, 2023
Mar. 31, 2023
Current assets:  
Cash and cash equivalents$ 195,585$ 208,357
Accounts receivable (net of allowances of $27,951 and $23,427, respectively)964,022928,315
Inventories, net855,617695,493
Prepaid expenses and other current assets203,729179,277
Total current assets2,218,9532,011,442
Property, plant, and equipment, net1,844,4841,705,512
Operating Lease, Right-of-Use Asset195,413191,741
Goodwill4,111,6833,879,219
Intangible Assets, Net (Excluding Goodwill)2,987,2872,955,780
Other assets77,33578,145
Total assets11,435,15510,821,839
Current liabilities:  
Accounts payable276,730279,620
Accrued income taxes24,88043,804
Accrued payroll and other related liabilities178,838125,642
Capital Lease Obligations, Current36,71134,961
Short-term Debt78,43860,000
Accrued expenses and other318,097317,817
Total current liabilities913,694861,844
Long-term indebtedness3,231,0753,018,655
Deferred Income Taxes and Other Tax Liabilities, Noncurrent621,071617,538
Capital Lease Obligations, Noncurrent162,827160,493
Other Liabilities, Noncurrent78,38976,137
Total liabilities5,007,0564,734,667
Commitments and contingencies (see Note 8)
Common shares, with $0.001 par value; 500,000 authorized; 98,808 shares issued; and 98,629 shares outstanding, respectively.4,534,2594,486,375
Retained earnings2,133,7661,911,533
Accumulated other comprehensive income(252,629)(320,710)
Total shareholders' equity6,415,3966,077,198
Noncontrolling interest12,7039,974
Total equity6,428,0996,087,172
Total liabilities and equity$ 11,435,155$ 10,821,839
STE
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
 CEO
 WEBSITEsteris.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES17000

STERIS PLC Frequently Asked Questions


What is the ticker symbol for STERIS PLC? What does STE stand for in stocks?

STE is the stock ticker symbol of STERIS PLC. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of STERIS PLC (STE)?

As of Thu Apr 18 2024, market cap of STERIS PLC is 19.83 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of STE stock?

You can check STE's fair value in chart for subscribers.

What is the fair value of STE stock?

You can check STE's fair value in chart for subscribers. The fair value of STERIS PLC is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of STERIS PLC is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for STE so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is STERIS PLC a good stock to buy?

The fair value guage provides a quick view whether STE is over valued or under valued. Whether STERIS PLC is cheap or expensive depends on the assumptions which impact STERIS PLC's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for STE.

What is STERIS PLC's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 18 2024, STE's PE ratio (Price to Earnings) is 34.98 and Price to Sales (PS) ratio is 3.67. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. STE PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on STERIS PLC's stock?

In the past 10 years, STERIS PLC has provided 0.159 (multiply by 100 for percentage) rate of return.